NEPHROFLOW Drug Patent Profile
✉ Email this page to a colleague
When do Nephroflow patents expire, and what generic alternatives are available?
Nephroflow is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in NEPHROFLOW is iodohippurate sodium i-123. Additional details are available on the iodohippurate sodium i-123 profile page.
US Patents and Regulatory Information for NEPHROFLOW
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | NEPHROFLOW | iodohippurate sodium i-123 | INJECTABLE;INJECTION | 018289-001 | Dec 28, 1984 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
